Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cosentino, F.
Right arrow Articles by Katusic, Z. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cosentino, F.
Right arrow Articles by Katusic, Z. S.

Stroke, Vol 25, 904-908, Copyright © 1994 by American Heart Association


ARTICLES

Does endothelin-1 play a role in the pathogenesis of cerebral vasospasm?

F Cosentino and ZS Katusic
Department of Anesthesiology, Mayo Clinic, Rochester, Minn. 55905.

BACKGROUND: Endothelin-1 is a very powerful endogenous vasoconstrictor substance produced by endothelial cells. Its long-lasting vasoconstrictor and hypertensive action has been well documented in several species, including humans. SUMMARY OF REVIEW: It is generally accepted that endothelin-1 may contribute to the pathogenesis of a number of cardiovascular diseases. In the cerebral vasculature, endothelin-1 has been proposed as a key mediator of cerebral vasospasm following subarachnoid hemorrhage. Availability of endothelin-1 antagonist provided a pharmacologic tool to test the role of endothelin in the development of vasospasm. CONCLUSIONS: This brief review is focused on the controversial results reported by different groups concerning the possible role of endothelin-1 in narrowing of cerebral arteries exposed to autologous blood.


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Gules, M. Satoh, B. R. Clower, A. Nanda, and J. H. Zhang
Comparison of three rat models of cerebral vasospasm
Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2551 - H2559.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Iglarz, J. Benessiano, I. Philip, S. Vuillaumier-Barrot, S. Lasocki, U. Hvass, G. Durand, J.-M. Desmonts, B. I. Levy, and D. Henrion
Preproendothelin-1 Gene Polymorphism Is Related to a Change in Vascular Reactivity in the Human Mammary Artery In Vitro
Hypertension, February 1, 2002; 39(2): 209 - 213.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. Mascia, L. Fedorko, D. J. Stewart, F. Mohamed, K. terBrugge, V. M. Ranieri, M. C. Wallace, and R. M. Pluta
Temporal Relationship Between Endothelin-1 Concentrations and Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage Editorial Comment : Endothelin-1 in Vasospasm After SAH
Stroke, May 1, 2001; 32(5): 1185 - 1190.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. Naredi, G. Lambert, E. Eden, S. Zall, M. Runnerstam, B. Rydenhag, and P. Friberg
Increased Sympathetic Nervous Activity in Patients With Nontraumatic Subarachnoid Hemorrhage
Stroke, April 1, 2000; 31(4): 901 - 906.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Y. Zubkov, K. S. Rollins, A. D. Parent, J. Zhang, and R. M. Bryan Jr
Mechanism of Endothelin-1-Induced Contraction in Rabbit Basilar Artery • Editorial Comment
Stroke, February 1, 2000; 31(2): 526 - 533.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Henrion, M. Iglarz, and B. I. Levy
Chronic Endothelin-1 Improves Nitric Oxide–Dependent Flow-Induced Dilation in Resistance Arteries From Normotensive and Hypertensive Rats
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2148 - 2153.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
N. F. Voelkel, J. D. Allard, S. M. Anderson, and T. J. Burke
cGMP and cAMP cause pulmonary vasoconstriction in the presence of hemolysate
J Appl Physiol, May 1, 1999; 86(5): 1715 - 1720.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
L. N. Pierre, A. P. Davenport, and Z. S. Katusic
Blockade and Reversal of Endothelin-Induced Constriction in Pial Arteries From Human Brain • Editorial Comment
Stroke, March 1, 1999; 30(3): 638 - 643.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Sima, B. K. A. Weir, R. L. Macdonald, and H. Zhang
Extracellular Nucleotide-Induced [Ca2+]i Elevation in Rat Basilar Smooth Muscle Cells
Stroke, October 1, 1997; 28(10): 2053 - 2059.
[Abstract] [Full Text]


Home page
StrokeHome page
T. Kasemsri, W. M. Armstead, and L. J. Noble
Endothelin Production Links Superoxide Generation to Altered Opioid-Induced Pial Artery Vasodilation After Brain Injury in Pigs
Stroke, January 1, 1997; 28(1): 190 - 197.
[Abstract] [Full Text]


Home page
StrokeHome page
C.-J. Kim, M. Bassiouny, R. L. Macdonald, B. Weir, L. M. Johns, and J. E. Brayden
Effect of BQ-123 and Tissue Plasminogen Activator on Vasospasm After Subarachnoid Hemorrhage in Monkeys
Stroke, September 1, 1996; 27(9): 1629 - 1633.
[Abstract] [Full Text]


Home page
HypertensionHome page
T. Kitazono, D. D. Heistad, and F. M. Faraci
Enhanced Responses of the Basilar Artery to Activation of Endothelin-B Receptors in Stroke-Prone Spontaneously Hypertensive Rats
Hypertension, April 1, 1995; 25(4): 490 - 494.
[Abstract] [Full Text]